Five best practice safety approaches.
Outsourcing without focusing on safety, however, is turning out to be a costly decision for some companies, leading to mistakes and budget overrun. For many clinical research organizations (CROs), offering full-service outsourcing, safety is too often an add-on.
The risk of this approach is the safety team is not sufficiently knowledgeable to ensure full compliance or to support clinical trials efficiently.
Delays and inefficiencies have led to pharmaceutical businesses having to double or even triple their clinical safety budget.
This guide offers practical actions for pharmaceutical businesses considering how to go about embedding safety into their outsourcing arrangements.